Advertisement

Topics

US Launch Of Sensipar Generics May Await Patent Case Even After FDA Approval

20:26 EDT 13 Mar 2018 | SCRIP

Aurobindo remains embroiled in litigation with Amgen on a Sensipar formulation patent, while Cipla settled ahead of  bench trial. Generic...

      

Related Stories

 

Original Article: US Launch Of Sensipar Generics May Await Patent Case Even After FDA Approval

NEXT ARTICLE

More From BioPortfolio on "US Launch Of Sensipar Generics May Await Patent Case Even After FDA Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...